• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·ATTO
Share

Attovia Therapeutics, Inc. Stocks

$ 18.06Last Updated 12.08.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

$ 18.06
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

09.08.2026 21:00

Robots Backed by DeepSeek Investments and a Wave of Biotech IPOs: Key Takeaways on IPOs Through August 9

05.08.2026 15:00

Attovia IPO: Goldman-backed biotech debuts on the Nasdaq

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.08.2026 17:00

Tencent is no longer China's most valuable company. The new market leader has been in the top spot for less than three weeks.

13.08.2026 16:58

Shares of broker Marex soared to a record high. The company benefited from market volatility.

13.08.2026 16:09

"Short sellers have run out of steam": The share of short positions in SpaceX fell by two-thirds over the course of the week

13.08.2026 15:41

Morning in New York: Focus on the Producer Price Index

13.08.2026 15:23

Denmark's Maersk raised its profit forecast for the second time this year. Its shares surged

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026